Kinetic Analysis of [11C]MP4A Using a High-Radioactivity Brain Region That Represents an Integrated Input Function for Measurement of Cerebral Acetylcholinesterase Activity without Arterial Blood Sampling
暂无分享,去创建一个
Hitoshi Shinotoh | Shuji Tanada | Noriko Tanaka | Kiyoshi Fukushi | Toshiaki Irie | Masaomi Iyo | M. Iyo | S. Tanada | H. Namba | A. Aotsuka | K. Fukushi | T. Irie | H. Shinotoh | S. Nagatsuka | N. Tanaka | T. Ota | Akiyo Aotsuka | Tsuneyoshi Ota | Hiroki Namba | Shin-Ichiro Nagatsuka
[1] K Kosaka,et al. [A biochemical study of cholinergic neurons of the post-mortem brains from the patients with Alzheimer-type dementia]. , 1984, Rinsho shinkeigaku = Clinical neurology.
[2] Hitoshi Shinotoh,et al. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease , 1997, The Lancet.
[3] S. Minoshima,et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease , 1999, Neurology.
[4] D. Kuhl,et al. In vivo studies of acetylcholinesterase activity using a labeled substrate, N‐[11C]methylpiperdin‐4‐yl propionate ([11C]PMP) , 1996, Synapse.
[5] E K Perry,et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.
[6] K. Fukushi,et al. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. , 1994, Nuclear medicine and biology.
[7] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[8] M. Iyo,et al. In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog , 1994, Brain Research.
[9] K. Davis,et al. Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.
[10] S Tanada,et al. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy , 1999, Annals of neurology.
[11] M. Iyo,et al. Positron Emission Tomographic Measurement of Brain Acetylcholinesterase Activity Using N-[11C]methylpiperidin-4-yl Acetate Without Arterial Blood Sampling: Methodology of Shape Analysis and its Diagnostic Power for Alzheimer's Disease , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] G Blomqvist,et al. On the Construction of Functional Maps in Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] S. Tanada,et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study , 2000, Annals of neurology.
[14] E. Perry,et al. Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System , 1986, Journal of neurochemistry.
[15] M. Iyo,et al. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] David E. Kuhl,et al. Kinetic Modeling of N-[11C]Methylpiperidin-4-yl Propionate: Alternatives for Analysis of an Irreversible Positron Emission Tomography Tracer for Measurement of Acetylcholinesterase Activity in Human Brain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] Hitoshi Shinotoh,et al. Preserved acetylcholinesterase activity in aged cerebral cortex , 1998, The Lancet.
[18] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[19] Hitoshi Shinotoh,et al. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age , 1999, European Journal of Nuclear Medicine.
[20] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.